Profile
Home  /   Staff  /   Researcher Profiles  /  Dr Nikki Verrills  /  Research Funding

Dr Nicole ( Nikki ) Verrills

Work Phone (02) 4921 5619
Fax (02) 4921 6903
Email
Office LS3-46, Life Sciences

Funding

Summary

Number of grants 46
Total funding $7,594,563

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

Seeking students for this project. - Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (3 grants)

Targeting PP2A to improve the therapeutic efficacy of mutant BRAF inhibitors in melanoma$359,250
Funding Body: Cancer Council NSW

Ultra-Low Temperature Cryogenic Freezer$24,596
Funding Body: NHMRC (National Health & Medical Research Council)

Proteomics of Cancer$6,000
Funding Body: Hunter Medical Research Institute

2012 (8 grants)

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$294,301
Funding Body: Cancer Institute NSW

Activating a tumour suppressor for leukaemia therapy$260,000
Funding Body: Cancer Council NSW

Activating a tumour suppressor for leukaemia therapy they receive$100,000
Funding Body: Cure Cancer Australia Foundation

Microscopic illumination system for advanced fluorescent protein technology$34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Activating a tumour suppressor for leukaemia therapy$20,000
Funding Body: University of Newcastle

Regulation of the cell cycle by phosphorylation dependent targeting of CaMKII$20,000
Funding Body: University of Newcastle

Role of CaMKII targeting in neuronal susceptibility to excitotoxic cell death$20,000
Funding Body: University of Newcastle

FASEB Protein Phosphatases, Snowmass, Colorado USA, 15 - 20 July 2012$1,500
Funding Body: University of Newcastle - Faculty of Health

2011 (7 grants)

Molecular characterisation of TRAIL-regulated signal transduction pathways and their role in the development, persistence, and exacerbation of allergic airways disease$615,048
Funding Body: NHMRC (National Health & Medical Research Council)

Targeting a tumour suppressor, PP2AS for new Leukaemia therapies$600,000
Funding Body: Cancer Institute NSW

Chemical Biology$444,961
Funding Body: University of Newcastle

Preclinical testing of PP2A activating compounds for the treatment of childhood acute lymphoblastic leukaemia$40,000
Funding Body: Hunter Medical Research Institute

Regulation of Breast Cancer Growth by a Novel Phosphorylation-Dependent Targeting Mechanism$35,000
Funding Body: Hunter Medical Research Institute

Targeting PP2A as a Novel Therapeutic Strategy for mutant FLT3* Acute Myeloid Leukaemia$25,000
Funding Body: Hunter Medical Research Institute

IMPLEN NanoPhotometer pearl$10,000
Funding Body: NHMRC (National Health & Medical Research Council)

2010 (4 grants)

An Integrated LC-MS-NMR facility for Applications in Proteomics and Organic Chemistry$500,000
Funding Body: Australian Research Council

An Integrated LC-MS-NMR facility for Applications in Proteomics and Organic Chemistry$280,000
Funding Body: University of Newcastle

ABI 7500 Real Time PCR System $34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Epigenetic methylation of PP2A subunit promoters in breast cancer$25,000
Funding Body: Hunter Children`s Research Foundation

2009 (4 grants)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$495,000
Funding Body: Australian Research Council

Tetraspanin proteins in prostate cancer progression and prognosis$341,000
Funding Body: Cancer Council NSW

Confocal Laser Scanning Microscopy for Live Cell Imaging$275,000
Funding Body: Australian Research Council

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$50,000
Funding Body: Australian Research Council

2008 (5 grants)

HMRI Cancer Research Program - MRSP Infrastructure$1,031,290
Funding Body: Hunter Medical Research Institute

PP2A: a novel target for leukaemia therapy$300,000
Funding Body: Cancer Council NSW

Functional investigations of novel SET splice isoforms in acute myeloid leukaemia and their potential as a therapeutic target.$270,000
Funding Body: Anthony Rothe Memorial Trust

Novel Alternative Splice Isoforms of the SET Oncogene in Acute Myeloid Leukaemia $25,000
Funding Body: Hunter Medical Research Institute

PP2A: A new target for asthma therapy$20,000
Funding Body: University of Newcastle

2007 (7 grants)

FACSAria - Fluorescence activated cell sorter$300,000
Funding Body: Cancer Institute NSW

The role of protein phosphatase 2A in breast cancer$75,000
Funding Body: Cure Cancer Australia Foundation

HMRI Contribution toward FACSAria - Fluorescence activated cell sorter$52,000
Funding Body: Hunter Medical Research Institute

Differential regulation of human mast cell degranulation by discrete forms of protein phosphatase 2A$50,000
Funding Body: Asthma Foundation of New South Wales

The tumour suppressor gene, PP2A, in breast cancer and its potential as a new target for therapy$29,930
Funding Body: Ramaciotti Foundations

Polymerase Chain Reaction (PCR) machine and Spectrophotometer$20,000
Funding Body: NHMRC (National Health & Medical Research Council)

American Association of Cancer Research, LA Convention Centre, Los Angeles, USA, 14/4/2007 - 18/4/2007$1,700
Funding Body: University of Newcastle

2006 (6 grants)

The role of protein phosphates in regulating the cytoskeletal dynamics of cancer cells$292,062
Funding Body: NHMRC (National Health & Medical Research Council)

Live cell imaging facility$149,100
Funding Body: Cancer Institute NSW

Investigating the functional role of altered expression and point mutations in the tumour suppressor gene PP2A$50,000
Funding Body: Hunter Medical Research Institute

Novel protein phosphatase interactions in cancer$10,000
Funding Body: Hunter Medical Research Institute

High speed computer for a live cell imaging system$3,000
Funding Body: Hunter Medical Research Institute

BioRad Mini-PROTEAN3 Electrophoresis system$995
Funding Body: Hunter Medical Research Institute

2005 (1 grants)

Europhosphatases Conference 2005, 10-14 July 2005$2,430
Funding Body: University of Newcastle

2004 (1 grants)

12th International Conference on Second Messenger and Phosphoproteins, 3-7 August 2004$2,400
Funding Body: University of Newcastle